Trevi Therapeutics (NASDAQ: TRVI) Announces At-the-Market Private Placement Seeking Gross Proceeds of $55 Million
Trevi Therapeutics, Inc. (NASDAQ: TRVI) operates as a clinical-stage biopharmaceutical company, which is focused on the research, development and commercialization ...